Evaluation of the CpG island methylator phenotype as a predictive biomarker for adjuvant oxaliplatin-based chemotherapy in colorectal cancer.

被引:0
|
作者
Shiovitz, Stacey
Wu, Chen
Yu, Ming
Gourgioti, Georgia
Raptou, Georgia
Kotoula, Vassiliki
Pentheroudakis, George E.
Kalogeras, Konstantine T.
Fountzilas, George
Grady, William M.
机构
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Hellen Cooperat Oncol Grp, Athens, Greece
[3] Aristotle Univ Thessaloniki, Sch Med, GR-54006 Thessaloniki, Greece
[4] Hellen Fdn Canc Res, Mol Oncol Lab, Athens, Greece
关键词
D O I
10.1200/jco.2015.33.3_suppl.592
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
592
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer
    Shailesh Mahesh Advani
    Pragati Shailesh Advani
    Derek W. Brown
    Stacia M. DeSantis
    Krittiya Korphaisarn
    Helena M. VonVille
    Jan Bressler
    David S. Lopez
    Jennifer S. Davis
    Carrie R. Daniel
    Amir Mehrvarz Sarshekeh
    Dejana Braithwaite
    Michael D. Swartz
    Scott Kopetz
    BMC Cancer, 19
  • [22] MIR-133A IS A PREDICTIVE BIOMARKER IN PATIENTS WITH METASTATIC COLORECTAL CANCER RECEIVING OXALIPLATIN-BASED CHEMOTHERAPY
    Ng, Simon S.
    Dong, Yujuan
    Leung, Wing Wa
    Ma, Brigette B.
    To, Ka Fai
    Sung, Joseph J.
    Yu, Jun
    GASTROENTEROLOGY, 2018, 154 (06) : S88 - S88
  • [23] Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer
    Advani, Shailesh Mahesh
    Advani, Pragati Shailesh
    Brown, Derek W.
    DeSantis, Stacia M.
    Korphaisarn, Krittiya
    VonVille, Helena M.
    Bressler, Jan
    Lopez, David S.
    Davis, Jennifer S.
    Daniel, Carrie R.
    Sarshekeh, Amir Mehrvarz
    Braithwaite, Dejana
    Swartz, Michael D.
    Kopetz, Scott
    BMC CANCER, 2019, 19 (01)
  • [24] Impact of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.
    Peixoto, Renata D'Alpino
    Kumar, Aalok
    Speers, Caroline
    Renouf, Daniel John
    Kennecke, Hagen F.
    Lim, Howard John
    Cheung, Winson Y.
    Melosky, Barbara L.
    Gill, Sharlene
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [25] Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample
    Ogino, Shuji
    Kawasaki, Takako
    Kirkner, Gregory J.
    Kraft, Peter
    Loda, Massimo
    Fuchs, Charles S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2007, 9 (03): : 305 - 314
  • [26] Oxaliplatin-based chemotherapy in the management of colorectal cancer
    Capdevila, Jaume
    Elez, Elena
    Peralta, Sergio
    Macarulla, Teresa
    Javier Ramos, Francisco
    Tabernero, Josep
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (08) : 1223 - 1236
  • [27] CPG ISLAND METHYLATOR PHENOTYPE AND MICROSATELLITE INSTABILITY AS A PROGNOSTIC FACTOR IN COLON CANCER TREATED WITH ADJUVANT FOLFOX CHEMOTHERAPY
    Lee, H. J.
    Han, S.
    Bae, J. M.
    Oh, D.
    Im, S.
    Park, K. J.
    Bang, Y.
    Park, J. G.
    Kang, G. H.
    Kim, T.
    ANNALS OF ONCOLOGY, 2010, 21 : 208 - 208
  • [28] Inflammatory cytokines and toxic effects of oxaliplatin-based chemotherapy in patients with colorectal cancer.
    Wang, X. S.
    Cleeland, C. S.
    Johnson, V. E.
    Reuben, J. M.
    Fogelman, D. R.
    Malekifar, M.
    Liao, K. E.
    Liu, P.
    Cohen, E. N.
    Gilmore, K. R.
    Eng, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [29] Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer
    Yongjun Cha
    Kyung-Ju Kim
    Sae-Won Han
    Ye Young Rhee
    Jeong Mo Bae
    Xianyu Wen
    Nam-Yun Cho
    Dae-Won Lee
    Kyung-Hun Lee
    Tae-Yong Kim
    Do-Youn Oh
    Seock-Ah Im
    Yung-Jue Bang
    Seung-Yong Jeong
    Kyu Joo Park
    Gyeong Hoon Kang
    Tae-You Kim
    British Journal of Cancer, 2016, 115 : 164 - 171
  • [30] No association of CpG island methylator phenotype and colorectal cancer survival: population-based study
    Jia, Min
    Jansen, Lina
    Walter, Viola
    Tagscherer, Katrin
    Roth, Wilfried
    Herpel, Esther
    Kloor, Matthias
    Blaeker, Hendrik
    Chang-Claude, Jenny
    Brenner, Hermann
    Hoffmeister, Michael
    BRITISH JOURNAL OF CANCER, 2016, 115 (11) : 1359 - 1366